• 

• CAS 9007-92-5 GLUCAGON HYDROCHLORIDE(HUMAN)

  Description GlucaGon, a recombinant DNA product, was developed as a nasal formulation of glucagon for the treatment of insulin-induced hypoglycemia. Glucagon is widely used by insulin dependent diabetic patients as an emergency treatment for severe hypoglycemic reactions. Use of genetically engineered glucagon by both intranasal and intramuscular methods has a similar effect on hepatic glucose production rate as natural glucagon from pancreatic extraction.

  Price on request

  REQUEST NOW

Product Introduction:

Product Name: GLUCAGON HYDROCHLORIDE(HUMAN)

Synonyms: Hyperglycemic-glycogenolytic factor;l-l-alpha-aspartyl-l-seryl-l-arginyl-l-arginyl-l-alanyl-l-glutaminyl-l-alpha-a;spartyl-l-phenylalanyl-l-valyl-l-glutaminyl-l-tryptophyl-l-leucyl-l-methionyl-;threonyl-l-seryl-l-alpha-aspartyl-l-tyrosyl-l-seryl-l-lysyl-l-tyrosyl-l-leucy;GLUCAGON HYDROCHLORIDE(HUMAN);glucagon[pig];glukagonnovo;his-ser-glu(nh2)-gly-thr-phe-thr-ser-asp-tyr-ser-lys-tyr-leu-asp-ser-arg-arg-a

CAS: 9007-92-5

MF: C153H226ClN43O49S

MW: 3519.21

EINECS: 232-708-2